Anastrozole API IP BP USP

Anastrozole API IP BP USP Specification

Purity(%)
99.9+

Product Type
Other

Category
Other

Usage
Advanced breast cancer

Ingredients
Other

Form
Powder

Grade
Pharma

Recommended For
Women

Shelf Life
3 Years

Storage Instructions
Room Temperature

Anastrozole API IP BP USP Trade Information

Minimum Order Quantity
1000 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
5 Kilograms Per Day

Delivery Time
3 Days

Sample Available
No

Packaging Details
BAG

Main Export Market(s)
Middle East, Africa, Eastern Europe, Western Europe, Asia, Australia, Central America, North America, South America

Main Domestic Market
All India

Certifications
DRUG LICENCE

About Anastrozole API IP BP USP

Anastrozole (commonly sold under the brand name Arimidex) is a prescription aromatase inhibitor used to treat and prevent hormone receptor-positive breast cancer in postmenopausal women. It works by decreasing estrogen production in the body, slowing or stopping the growth of cancer cells that rely on estrogen to multiply. How It Works

Mechanism: It blocks the aromatase enzyme, which converts androgens into estrogen in peripheral tissues (like fat and muscle).
Who it's for: Exclusively used in postmenopausal women because a woman's ovaries stop producing most estrogen, making these peripheral tissues the primary source.

Common Uses

Early-stage breast cancer: Taken as an "adjuvant" therapy (alongside surgery or radiation) to prevent cancer from returning.
Advanced breast cancer: Used as a first-line treatment if the cancer has spread, or following treatments like tamoxifen.
Prevention: Occasionally used off-label to prevent breast cancer in women who are at a very high risk